We are live on
!
Find out more
BIOS
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
BIOS
Delisted
BIOS was delisted on the 6th of October, 2023.
61 hedge funds and large institutions have $231M invested in BioPlus Acquisition Corp. Class A Ordinary Shares in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
8% more capital invested
Capital invested by funds: $213M → $231M (+$17.4M)
8% less funds holding
Funds holding: 66 → 61 (-5)
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Holders
61
Holders Change
-5
Holders Change %
-7.58%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
14
Closed
10
Calls
$104K
Puts
–
Net Calls
+$104K
Net Calls Change
+$1K
Top Buyers
Top Sellers
| 1 |
HCM
Highbridge Capital Management
New York
|
-$15.2M |
| 2 |
Millennium Management
New York
|
-$10.3M |
| 3 |
SCM
Saba Capital Management
New York
|
-$7.77M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$5.16M |
| 5 |
TCA
Taconic Capital Advisors
New York
|
-$5.14M |
